Zogenix reported $272.86M in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 564.84M 16.77M
Acura Pharmaceuticals ACUR:US 382K 6.52M
Adamas Pharmaceuticals ADMS:US -4033000 9.97M
Aerie Pharmaceuticals AERI:US $ -39.61M 29.25M
Alnylam Pharmaceuticals ALNY:US $ 853.36M 72.83M
Arena Pharmaceuticals ARNA:US $ 971.08M 114.91M
AstraZeneca AZN:LN 15676M 1246M
Becton, Dickinson and BDX:US $ 24135M 691M
Biocryst Pharmaceuticals BCRX:US $ -106.08M 31.09M
Biogen BIIB:US $ 10751.9M 69.7M
Cardinal Health CAH:US 1.79B 4M
Esperion Therapeutics ESPR:US $ -304310000 34.92M
Flexion Therapeutics FLXN:US $ -56171000 17.3M
GlaxoSmithKline GSK:LN 15377M 512M
Gw Pharmaceuticals GWPH:US $ 736.37M 4.72M
Heron Therapeutics HRTX:US $ 160.11M 36.11M
Intra Cellular Therapies ITCI:US $ 553.59M 58.56M
Marinus Pharmaceuticals MRNS:US $ 95.06M 20.27M
Nektar Therapeutics NKTR:US $ 904.98M 89.53M
Neurocrine Biosciences NBIX:US $ 1279.2M 73.6M
Revance Therapeutics RVNC:US $ 186.24M 58.01M
Sarepta Therapeutics SRPT:US $ 485.11M 50.34M
Teva Pharmaceutical TEVA:IT 10.32B 324M
Zogenix ZGNX:US $ 272.86M 48.42M